• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back To Search Results
FR Publication Date: 01/30/2014 

Part B: Supplementary Information

ANSI / RESNA WC/Volume 1 - 1998, section 13: determination of coefficient of friction of test surfaces. (Physical Medicine)
Addresses of Standards Development Organizations:
 American National Standards Institute (ANSI)
  25 West 43rd Street
  4th Floor
  New York, NY 10036
 Rehabilitation Engineering and Assistive Technology Society of North America (RESNA)
  1700 N. Moore Street
  Suite 1540
  Arlington, VA 22209-1903
CDRH Office and Division associated with recognized standards:
Devices Affected:
Mechanical Wheelchairs, Powered Wheelchairs and Motorized 3-Wheeled Vehicles (Scooters)
Processes Affected:
510(K), IDE, PMA, PDP, Design Controls
Type of Standard:
 Test Methods, National, Vertical
Extent of Recognition:
Complete Standard.

Standard specifies a test method for determining the coefficient of friction of a test surface that has a rough texture, such as unfinished concrete. In the event that the test method is used for smooth or polished surfaces, care should be exercised that the coefficient of friction is measured as being constant over the whole area of the test surfaces.
Related CFR Citations and Product Codes:
Device Name Device
§890.3800 Vehicle, Motorized 3-Wheeled Class 2 INI
§890.3850 Wheelchair, Mechanical Class 1 IOR
§890.3860 Wheelchair, Powered Class 2 ITI
§890.3880 Wheelchair, Special Grade Class 2 IQC
§890.3890 Wheelchair, Stair Climbing Class 2 IMK
§890.3900 Wheelchair, Standup Class 2 IPL
§890.3930 Elevator, Wheelchair, Portable Class 2 ING
FDA Technical Contact:
 Laurence Coyne
  10903 New Hampshire Avenue Building 66, Room 1526
  Silver Spring MD 20993
  email: laurence.coyne@fda.hhs.gov